| Vision Care Associates, Llp | |
|
310 8th Ave Nw, Aberdeen, SD 57401-2365 | |
| (605) 225-2020 | |
| (605) 226-2614 |
| Full Name | Vision Care Associates, Llp |
|---|---|
| Type | Facility |
| Speciality | Optometrist |
| Location | 310 8th Ave Nw, Aberdeen, South Dakota |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265502264 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | E (South Dakota) | Primary |
| Provider Name | Laura J Slowey |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1992777221 PECOS PAC ID: 8729981428 Enrollment ID: I20040129001117 |
News Archive
Baxter International Inc. today confirmed that the European Commission (EC) has granted marketing authorization for CELVAPAN H1N1 pandemic vaccine using Baxter's Vero cell technology. CELVAPAN H1N1 is the first cell culture-based and non-adjuvanted pandemic influenza vaccine to receive marketing authorization in the European Union.
Pancreatic cancer carries a poor prognosis, and it often goes undetected until advanced stages. A new BJS (British Journal of Surgery) study indicates that a certain cocktail of chemotherapy drugs may be a safe and effective treatment option for patients with a metastatic form of the disease.
Research calling for the use of a wearable computing system installed in a helmet to protect construction workers from carbon monoxide poisoning, a serious lethal threat in this industry, has garnered the Virginia Tech investigators a Best Paper Award from a prestigious scientific and engineering community.
Electromed, Inc. today announced financial results for the three-month period ended September 30, 2011. Net Revenues for the three months ended September 30, 2011 were approximately $5,379,000, a 29.1% increase compared to Net Revenues of approximately $4,165,000 for the same period last year.
› Verified 5 days ago
| Provider Name | Amy M Dejong |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1013997147 PECOS PAC ID: 9133115066 Enrollment ID: I20040428000283 |
News Archive
Baxter International Inc. today confirmed that the European Commission (EC) has granted marketing authorization for CELVAPAN H1N1 pandemic vaccine using Baxter's Vero cell technology. CELVAPAN H1N1 is the first cell culture-based and non-adjuvanted pandemic influenza vaccine to receive marketing authorization in the European Union.
Pancreatic cancer carries a poor prognosis, and it often goes undetected until advanced stages. A new BJS (British Journal of Surgery) study indicates that a certain cocktail of chemotherapy drugs may be a safe and effective treatment option for patients with a metastatic form of the disease.
Research calling for the use of a wearable computing system installed in a helmet to protect construction workers from carbon monoxide poisoning, a serious lethal threat in this industry, has garnered the Virginia Tech investigators a Best Paper Award from a prestigious scientific and engineering community.
Electromed, Inc. today announced financial results for the three-month period ended September 30, 2011. Net Revenues for the three months ended September 30, 2011 were approximately $5,379,000, a 29.1% increase compared to Net Revenues of approximately $4,165,000 for the same period last year.
› Verified 5 days ago
| Provider Name | Thomas F Billars |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1043230584 PECOS PAC ID: 7618942152 Enrollment ID: I20040830000165 |
News Archive
Baxter International Inc. today confirmed that the European Commission (EC) has granted marketing authorization for CELVAPAN H1N1 pandemic vaccine using Baxter's Vero cell technology. CELVAPAN H1N1 is the first cell culture-based and non-adjuvanted pandemic influenza vaccine to receive marketing authorization in the European Union.
Pancreatic cancer carries a poor prognosis, and it often goes undetected until advanced stages. A new BJS (British Journal of Surgery) study indicates that a certain cocktail of chemotherapy drugs may be a safe and effective treatment option for patients with a metastatic form of the disease.
Research calling for the use of a wearable computing system installed in a helmet to protect construction workers from carbon monoxide poisoning, a serious lethal threat in this industry, has garnered the Virginia Tech investigators a Best Paper Award from a prestigious scientific and engineering community.
Electromed, Inc. today announced financial results for the three-month period ended September 30, 2011. Net Revenues for the three months ended September 30, 2011 were approximately $5,379,000, a 29.1% increase compared to Net Revenues of approximately $4,165,000 for the same period last year.
› Verified 5 days ago
| Provider Name | Thomas T Kessinger |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1962425637 PECOS PAC ID: 2466427844 Enrollment ID: I20040830000384 |
News Archive
Baxter International Inc. today confirmed that the European Commission (EC) has granted marketing authorization for CELVAPAN H1N1 pandemic vaccine using Baxter's Vero cell technology. CELVAPAN H1N1 is the first cell culture-based and non-adjuvanted pandemic influenza vaccine to receive marketing authorization in the European Union.
Pancreatic cancer carries a poor prognosis, and it often goes undetected until advanced stages. A new BJS (British Journal of Surgery) study indicates that a certain cocktail of chemotherapy drugs may be a safe and effective treatment option for patients with a metastatic form of the disease.
Research calling for the use of a wearable computing system installed in a helmet to protect construction workers from carbon monoxide poisoning, a serious lethal threat in this industry, has garnered the Virginia Tech investigators a Best Paper Award from a prestigious scientific and engineering community.
Electromed, Inc. today announced financial results for the three-month period ended September 30, 2011. Net Revenues for the three months ended September 30, 2011 were approximately $5,379,000, a 29.1% increase compared to Net Revenues of approximately $4,165,000 for the same period last year.
› Verified 5 days ago
| Provider Name | Aaron Feser |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1497775308 PECOS PAC ID: 5294780284 Enrollment ID: I20050311000924 |
News Archive
Baxter International Inc. today confirmed that the European Commission (EC) has granted marketing authorization for CELVAPAN H1N1 pandemic vaccine using Baxter's Vero cell technology. CELVAPAN H1N1 is the first cell culture-based and non-adjuvanted pandemic influenza vaccine to receive marketing authorization in the European Union.
Pancreatic cancer carries a poor prognosis, and it often goes undetected until advanced stages. A new BJS (British Journal of Surgery) study indicates that a certain cocktail of chemotherapy drugs may be a safe and effective treatment option for patients with a metastatic form of the disease.
Research calling for the use of a wearable computing system installed in a helmet to protect construction workers from carbon monoxide poisoning, a serious lethal threat in this industry, has garnered the Virginia Tech investigators a Best Paper Award from a prestigious scientific and engineering community.
Electromed, Inc. today announced financial results for the three-month period ended September 30, 2011. Net Revenues for the three months ended September 30, 2011 were approximately $5,379,000, a 29.1% increase compared to Net Revenues of approximately $4,165,000 for the same period last year.
› Verified 5 days ago
| Provider Name | John W Sivesind |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1285672246 PECOS PAC ID: 5395777908 Enrollment ID: I20050902000736 |
News Archive
Baxter International Inc. today confirmed that the European Commission (EC) has granted marketing authorization for CELVAPAN H1N1 pandemic vaccine using Baxter's Vero cell technology. CELVAPAN H1N1 is the first cell culture-based and non-adjuvanted pandemic influenza vaccine to receive marketing authorization in the European Union.
Pancreatic cancer carries a poor prognosis, and it often goes undetected until advanced stages. A new BJS (British Journal of Surgery) study indicates that a certain cocktail of chemotherapy drugs may be a safe and effective treatment option for patients with a metastatic form of the disease.
Research calling for the use of a wearable computing system installed in a helmet to protect construction workers from carbon monoxide poisoning, a serious lethal threat in this industry, has garnered the Virginia Tech investigators a Best Paper Award from a prestigious scientific and engineering community.
Electromed, Inc. today announced financial results for the three-month period ended September 30, 2011. Net Revenues for the three months ended September 30, 2011 were approximately $5,379,000, a 29.1% increase compared to Net Revenues of approximately $4,165,000 for the same period last year.
› Verified 5 days ago
| Provider Name | Paul Steven Anderson |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1356364236 PECOS PAC ID: 7113918384 Enrollment ID: I20060405000183 |
News Archive
Baxter International Inc. today confirmed that the European Commission (EC) has granted marketing authorization for CELVAPAN H1N1 pandemic vaccine using Baxter's Vero cell technology. CELVAPAN H1N1 is the first cell culture-based and non-adjuvanted pandemic influenza vaccine to receive marketing authorization in the European Union.
Pancreatic cancer carries a poor prognosis, and it often goes undetected until advanced stages. A new BJS (British Journal of Surgery) study indicates that a certain cocktail of chemotherapy drugs may be a safe and effective treatment option for patients with a metastatic form of the disease.
Research calling for the use of a wearable computing system installed in a helmet to protect construction workers from carbon monoxide poisoning, a serious lethal threat in this industry, has garnered the Virginia Tech investigators a Best Paper Award from a prestigious scientific and engineering community.
Electromed, Inc. today announced financial results for the three-month period ended September 30, 2011. Net Revenues for the three months ended September 30, 2011 were approximately $5,379,000, a 29.1% increase compared to Net Revenues of approximately $4,165,000 for the same period last year.
› Verified 5 days ago
| Provider Name | Kyle Porisch |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1275625071 PECOS PAC ID: 5991703779 Enrollment ID: I20061111000020 |
News Archive
Baxter International Inc. today confirmed that the European Commission (EC) has granted marketing authorization for CELVAPAN H1N1 pandemic vaccine using Baxter's Vero cell technology. CELVAPAN H1N1 is the first cell culture-based and non-adjuvanted pandemic influenza vaccine to receive marketing authorization in the European Union.
Pancreatic cancer carries a poor prognosis, and it often goes undetected until advanced stages. A new BJS (British Journal of Surgery) study indicates that a certain cocktail of chemotherapy drugs may be a safe and effective treatment option for patients with a metastatic form of the disease.
Research calling for the use of a wearable computing system installed in a helmet to protect construction workers from carbon monoxide poisoning, a serious lethal threat in this industry, has garnered the Virginia Tech investigators a Best Paper Award from a prestigious scientific and engineering community.
Electromed, Inc. today announced financial results for the three-month period ended September 30, 2011. Net Revenues for the three months ended September 30, 2011 were approximately $5,379,000, a 29.1% increase compared to Net Revenues of approximately $4,165,000 for the same period last year.
› Verified 5 days ago
| Provider Name | Darren R Dohman |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1265524078 PECOS PAC ID: 1052322856 Enrollment ID: I20061111000024 |
News Archive
Baxter International Inc. today confirmed that the European Commission (EC) has granted marketing authorization for CELVAPAN H1N1 pandemic vaccine using Baxter's Vero cell technology. CELVAPAN H1N1 is the first cell culture-based and non-adjuvanted pandemic influenza vaccine to receive marketing authorization in the European Union.
Pancreatic cancer carries a poor prognosis, and it often goes undetected until advanced stages. A new BJS (British Journal of Surgery) study indicates that a certain cocktail of chemotherapy drugs may be a safe and effective treatment option for patients with a metastatic form of the disease.
Research calling for the use of a wearable computing system installed in a helmet to protect construction workers from carbon monoxide poisoning, a serious lethal threat in this industry, has garnered the Virginia Tech investigators a Best Paper Award from a prestigious scientific and engineering community.
Electromed, Inc. today announced financial results for the three-month period ended September 30, 2011. Net Revenues for the three months ended September 30, 2011 were approximately $5,379,000, a 29.1% increase compared to Net Revenues of approximately $4,165,000 for the same period last year.
› Verified 5 days ago
| Provider Name | Craig Dockter |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1629090162 PECOS PAC ID: 0143351031 Enrollment ID: I20100621000495 |
News Archive
Baxter International Inc. today confirmed that the European Commission (EC) has granted marketing authorization for CELVAPAN H1N1 pandemic vaccine using Baxter's Vero cell technology. CELVAPAN H1N1 is the first cell culture-based and non-adjuvanted pandemic influenza vaccine to receive marketing authorization in the European Union.
Pancreatic cancer carries a poor prognosis, and it often goes undetected until advanced stages. A new BJS (British Journal of Surgery) study indicates that a certain cocktail of chemotherapy drugs may be a safe and effective treatment option for patients with a metastatic form of the disease.
Research calling for the use of a wearable computing system installed in a helmet to protect construction workers from carbon monoxide poisoning, a serious lethal threat in this industry, has garnered the Virginia Tech investigators a Best Paper Award from a prestigious scientific and engineering community.
Electromed, Inc. today announced financial results for the three-month period ended September 30, 2011. Net Revenues for the three months ended September 30, 2011 were approximately $5,379,000, a 29.1% increase compared to Net Revenues of approximately $4,165,000 for the same period last year.
› Verified 5 days ago
| Provider Name | Bruce M Siegling |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1487674305 PECOS PAC ID: 2567593452 Enrollment ID: I20100621000546 |
News Archive
Baxter International Inc. today confirmed that the European Commission (EC) has granted marketing authorization for CELVAPAN H1N1 pandemic vaccine using Baxter's Vero cell technology. CELVAPAN H1N1 is the first cell culture-based and non-adjuvanted pandemic influenza vaccine to receive marketing authorization in the European Union.
Pancreatic cancer carries a poor prognosis, and it often goes undetected until advanced stages. A new BJS (British Journal of Surgery) study indicates that a certain cocktail of chemotherapy drugs may be a safe and effective treatment option for patients with a metastatic form of the disease.
Research calling for the use of a wearable computing system installed in a helmet to protect construction workers from carbon monoxide poisoning, a serious lethal threat in this industry, has garnered the Virginia Tech investigators a Best Paper Award from a prestigious scientific and engineering community.
Electromed, Inc. today announced financial results for the three-month period ended September 30, 2011. Net Revenues for the three months ended September 30, 2011 were approximately $5,379,000, a 29.1% increase compared to Net Revenues of approximately $4,165,000 for the same period last year.
› Verified 5 days ago
| Provider Name | Marshall P Dorsett |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1427078997 PECOS PAC ID: 6002947900 Enrollment ID: I20100621000688 |
News Archive
Baxter International Inc. today confirmed that the European Commission (EC) has granted marketing authorization for CELVAPAN H1N1 pandemic vaccine using Baxter's Vero cell technology. CELVAPAN H1N1 is the first cell culture-based and non-adjuvanted pandemic influenza vaccine to receive marketing authorization in the European Union.
Pancreatic cancer carries a poor prognosis, and it often goes undetected until advanced stages. A new BJS (British Journal of Surgery) study indicates that a certain cocktail of chemotherapy drugs may be a safe and effective treatment option for patients with a metastatic form of the disease.
Research calling for the use of a wearable computing system installed in a helmet to protect construction workers from carbon monoxide poisoning, a serious lethal threat in this industry, has garnered the Virginia Tech investigators a Best Paper Award from a prestigious scientific and engineering community.
Electromed, Inc. today announced financial results for the three-month period ended September 30, 2011. Net Revenues for the three months ended September 30, 2011 were approximately $5,379,000, a 29.1% increase compared to Net Revenues of approximately $4,165,000 for the same period last year.
› Verified 5 days ago
| Provider Name | James A Olson |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1548283229 PECOS PAC ID: 4789715566 Enrollment ID: I20100622000707 |
News Archive
Baxter International Inc. today confirmed that the European Commission (EC) has granted marketing authorization for CELVAPAN H1N1 pandemic vaccine using Baxter's Vero cell technology. CELVAPAN H1N1 is the first cell culture-based and non-adjuvanted pandemic influenza vaccine to receive marketing authorization in the European Union.
Pancreatic cancer carries a poor prognosis, and it often goes undetected until advanced stages. A new BJS (British Journal of Surgery) study indicates that a certain cocktail of chemotherapy drugs may be a safe and effective treatment option for patients with a metastatic form of the disease.
Research calling for the use of a wearable computing system installed in a helmet to protect construction workers from carbon monoxide poisoning, a serious lethal threat in this industry, has garnered the Virginia Tech investigators a Best Paper Award from a prestigious scientific and engineering community.
Electromed, Inc. today announced financial results for the three-month period ended September 30, 2011. Net Revenues for the three months ended September 30, 2011 were approximately $5,379,000, a 29.1% increase compared to Net Revenues of approximately $4,165,000 for the same period last year.
› Verified 5 days ago
| Provider Name | Mark Struble |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1477575827 PECOS PAC ID: 3971607524 Enrollment ID: I20100622000724 |
News Archive
Baxter International Inc. today confirmed that the European Commission (EC) has granted marketing authorization for CELVAPAN H1N1 pandemic vaccine using Baxter's Vero cell technology. CELVAPAN H1N1 is the first cell culture-based and non-adjuvanted pandemic influenza vaccine to receive marketing authorization in the European Union.
Pancreatic cancer carries a poor prognosis, and it often goes undetected until advanced stages. A new BJS (British Journal of Surgery) study indicates that a certain cocktail of chemotherapy drugs may be a safe and effective treatment option for patients with a metastatic form of the disease.
Research calling for the use of a wearable computing system installed in a helmet to protect construction workers from carbon monoxide poisoning, a serious lethal threat in this industry, has garnered the Virginia Tech investigators a Best Paper Award from a prestigious scientific and engineering community.
Electromed, Inc. today announced financial results for the three-month period ended September 30, 2011. Net Revenues for the three months ended September 30, 2011 were approximately $5,379,000, a 29.1% increase compared to Net Revenues of approximately $4,165,000 for the same period last year.
› Verified 5 days ago
| Provider Name | John C Olson |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1902248099 PECOS PAC ID: 5991930083 Enrollment ID: I20131025001016 |
News Archive
Baxter International Inc. today confirmed that the European Commission (EC) has granted marketing authorization for CELVAPAN H1N1 pandemic vaccine using Baxter's Vero cell technology. CELVAPAN H1N1 is the first cell culture-based and non-adjuvanted pandemic influenza vaccine to receive marketing authorization in the European Union.
Pancreatic cancer carries a poor prognosis, and it often goes undetected until advanced stages. A new BJS (British Journal of Surgery) study indicates that a certain cocktail of chemotherapy drugs may be a safe and effective treatment option for patients with a metastatic form of the disease.
Research calling for the use of a wearable computing system installed in a helmet to protect construction workers from carbon monoxide poisoning, a serious lethal threat in this industry, has garnered the Virginia Tech investigators a Best Paper Award from a prestigious scientific and engineering community.
Electromed, Inc. today announced financial results for the three-month period ended September 30, 2011. Net Revenues for the three months ended September 30, 2011 were approximately $5,379,000, a 29.1% increase compared to Net Revenues of approximately $4,165,000 for the same period last year.
› Verified 5 days ago
| Provider Name | Keri D Nebelsick |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1477840478 PECOS PAC ID: 6305014549 Enrollment ID: I20140210001913 |
News Archive
Baxter International Inc. today confirmed that the European Commission (EC) has granted marketing authorization for CELVAPAN H1N1 pandemic vaccine using Baxter's Vero cell technology. CELVAPAN H1N1 is the first cell culture-based and non-adjuvanted pandemic influenza vaccine to receive marketing authorization in the European Union.
Pancreatic cancer carries a poor prognosis, and it often goes undetected until advanced stages. A new BJS (British Journal of Surgery) study indicates that a certain cocktail of chemotherapy drugs may be a safe and effective treatment option for patients with a metastatic form of the disease.
Research calling for the use of a wearable computing system installed in a helmet to protect construction workers from carbon monoxide poisoning, a serious lethal threat in this industry, has garnered the Virginia Tech investigators a Best Paper Award from a prestigious scientific and engineering community.
Electromed, Inc. today announced financial results for the three-month period ended September 30, 2011. Net Revenues for the three months ended September 30, 2011 were approximately $5,379,000, a 29.1% increase compared to Net Revenues of approximately $4,165,000 for the same period last year.
› Verified 5 days ago
| Provider Name | Bethany L Russell |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1558598284 PECOS PAC ID: 8820269863 Enrollment ID: I20141028002685 |
News Archive
Baxter International Inc. today confirmed that the European Commission (EC) has granted marketing authorization for CELVAPAN H1N1 pandemic vaccine using Baxter's Vero cell technology. CELVAPAN H1N1 is the first cell culture-based and non-adjuvanted pandemic influenza vaccine to receive marketing authorization in the European Union.
Pancreatic cancer carries a poor prognosis, and it often goes undetected until advanced stages. A new BJS (British Journal of Surgery) study indicates that a certain cocktail of chemotherapy drugs may be a safe and effective treatment option for patients with a metastatic form of the disease.
Research calling for the use of a wearable computing system installed in a helmet to protect construction workers from carbon monoxide poisoning, a serious lethal threat in this industry, has garnered the Virginia Tech investigators a Best Paper Award from a prestigious scientific and engineering community.
Electromed, Inc. today announced financial results for the three-month period ended September 30, 2011. Net Revenues for the three months ended September 30, 2011 were approximately $5,379,000, a 29.1% increase compared to Net Revenues of approximately $4,165,000 for the same period last year.
› Verified 5 days ago
| Provider Name | Jerika J Kirwan |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1174906705 PECOS PAC ID: 5193031532 Enrollment ID: I20150901000454 |
News Archive
Baxter International Inc. today confirmed that the European Commission (EC) has granted marketing authorization for CELVAPAN H1N1 pandemic vaccine using Baxter's Vero cell technology. CELVAPAN H1N1 is the first cell culture-based and non-adjuvanted pandemic influenza vaccine to receive marketing authorization in the European Union.
Pancreatic cancer carries a poor prognosis, and it often goes undetected until advanced stages. A new BJS (British Journal of Surgery) study indicates that a certain cocktail of chemotherapy drugs may be a safe and effective treatment option for patients with a metastatic form of the disease.
Research calling for the use of a wearable computing system installed in a helmet to protect construction workers from carbon monoxide poisoning, a serious lethal threat in this industry, has garnered the Virginia Tech investigators a Best Paper Award from a prestigious scientific and engineering community.
Electromed, Inc. today announced financial results for the three-month period ended September 30, 2011. Net Revenues for the three months ended September 30, 2011 were approximately $5,379,000, a 29.1% increase compared to Net Revenues of approximately $4,165,000 for the same period last year.
› Verified 5 days ago
| Provider Name | Kristen Kramlich |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1427408798 PECOS PAC ID: 4082906789 Enrollment ID: I20170502002273 |
News Archive
Baxter International Inc. today confirmed that the European Commission (EC) has granted marketing authorization for CELVAPAN H1N1 pandemic vaccine using Baxter's Vero cell technology. CELVAPAN H1N1 is the first cell culture-based and non-adjuvanted pandemic influenza vaccine to receive marketing authorization in the European Union.
Pancreatic cancer carries a poor prognosis, and it often goes undetected until advanced stages. A new BJS (British Journal of Surgery) study indicates that a certain cocktail of chemotherapy drugs may be a safe and effective treatment option for patients with a metastatic form of the disease.
Research calling for the use of a wearable computing system installed in a helmet to protect construction workers from carbon monoxide poisoning, a serious lethal threat in this industry, has garnered the Virginia Tech investigators a Best Paper Award from a prestigious scientific and engineering community.
Electromed, Inc. today announced financial results for the three-month period ended September 30, 2011. Net Revenues for the three months ended September 30, 2011 were approximately $5,379,000, a 29.1% increase compared to Net Revenues of approximately $4,165,000 for the same period last year.
› Verified 5 days ago
| Provider Name | Jarrell C Freitag |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1013401637 PECOS PAC ID: 9739436460 Enrollment ID: I20180806002533 |
News Archive
Baxter International Inc. today confirmed that the European Commission (EC) has granted marketing authorization for CELVAPAN H1N1 pandemic vaccine using Baxter's Vero cell technology. CELVAPAN H1N1 is the first cell culture-based and non-adjuvanted pandemic influenza vaccine to receive marketing authorization in the European Union.
Pancreatic cancer carries a poor prognosis, and it often goes undetected until advanced stages. A new BJS (British Journal of Surgery) study indicates that a certain cocktail of chemotherapy drugs may be a safe and effective treatment option for patients with a metastatic form of the disease.
Research calling for the use of a wearable computing system installed in a helmet to protect construction workers from carbon monoxide poisoning, a serious lethal threat in this industry, has garnered the Virginia Tech investigators a Best Paper Award from a prestigious scientific and engineering community.
Electromed, Inc. today announced financial results for the three-month period ended September 30, 2011. Net Revenues for the three months ended September 30, 2011 were approximately $5,379,000, a 29.1% increase compared to Net Revenues of approximately $4,165,000 for the same period last year.
› Verified 5 days ago
| Provider Name | Mary S Miller |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1275789455 PECOS PAC ID: 4082780945 Enrollment ID: I20210113003051 |
News Archive
Baxter International Inc. today confirmed that the European Commission (EC) has granted marketing authorization for CELVAPAN H1N1 pandemic vaccine using Baxter's Vero cell technology. CELVAPAN H1N1 is the first cell culture-based and non-adjuvanted pandemic influenza vaccine to receive marketing authorization in the European Union.
Pancreatic cancer carries a poor prognosis, and it often goes undetected until advanced stages. A new BJS (British Journal of Surgery) study indicates that a certain cocktail of chemotherapy drugs may be a safe and effective treatment option for patients with a metastatic form of the disease.
Research calling for the use of a wearable computing system installed in a helmet to protect construction workers from carbon monoxide poisoning, a serious lethal threat in this industry, has garnered the Virginia Tech investigators a Best Paper Award from a prestigious scientific and engineering community.
Electromed, Inc. today announced financial results for the three-month period ended September 30, 2011. Net Revenues for the three months ended September 30, 2011 were approximately $5,379,000, a 29.1% increase compared to Net Revenues of approximately $4,165,000 for the same period last year.
› Verified 5 days ago
| Provider Name | Olivia A Cotton |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1861083412 PECOS PAC ID: 2466867759 Enrollment ID: I20210218002270 |
News Archive
Baxter International Inc. today confirmed that the European Commission (EC) has granted marketing authorization for CELVAPAN H1N1 pandemic vaccine using Baxter's Vero cell technology. CELVAPAN H1N1 is the first cell culture-based and non-adjuvanted pandemic influenza vaccine to receive marketing authorization in the European Union.
Pancreatic cancer carries a poor prognosis, and it often goes undetected until advanced stages. A new BJS (British Journal of Surgery) study indicates that a certain cocktail of chemotherapy drugs may be a safe and effective treatment option for patients with a metastatic form of the disease.
Research calling for the use of a wearable computing system installed in a helmet to protect construction workers from carbon monoxide poisoning, a serious lethal threat in this industry, has garnered the Virginia Tech investigators a Best Paper Award from a prestigious scientific and engineering community.
Electromed, Inc. today announced financial results for the three-month period ended September 30, 2011. Net Revenues for the three months ended September 30, 2011 were approximately $5,379,000, a 29.1% increase compared to Net Revenues of approximately $4,165,000 for the same period last year.
› Verified 5 days ago
| Provider Name | Sara O Serfoss |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1508435652 PECOS PAC ID: 3274936711 Enrollment ID: I20210721003984 |
News Archive
Baxter International Inc. today confirmed that the European Commission (EC) has granted marketing authorization for CELVAPAN H1N1 pandemic vaccine using Baxter's Vero cell technology. CELVAPAN H1N1 is the first cell culture-based and non-adjuvanted pandemic influenza vaccine to receive marketing authorization in the European Union.
Pancreatic cancer carries a poor prognosis, and it often goes undetected until advanced stages. A new BJS (British Journal of Surgery) study indicates that a certain cocktail of chemotherapy drugs may be a safe and effective treatment option for patients with a metastatic form of the disease.
Research calling for the use of a wearable computing system installed in a helmet to protect construction workers from carbon monoxide poisoning, a serious lethal threat in this industry, has garnered the Virginia Tech investigators a Best Paper Award from a prestigious scientific and engineering community.
Electromed, Inc. today announced financial results for the three-month period ended September 30, 2011. Net Revenues for the three months ended September 30, 2011 were approximately $5,379,000, a 29.1% increase compared to Net Revenues of approximately $4,165,000 for the same period last year.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Vision Care Associates, Llp 310 8th Ave Nw, Aberdeen, SD 57401-2365 Ph: (605) 225-2020 | Vision Care Associates, Llp 310 8th Ave Nw, Aberdeen, SD 57401-2365 Ph: (605) 225-2020 |
News Archive
Baxter International Inc. today confirmed that the European Commission (EC) has granted marketing authorization for CELVAPAN H1N1 pandemic vaccine using Baxter's Vero cell technology. CELVAPAN H1N1 is the first cell culture-based and non-adjuvanted pandemic influenza vaccine to receive marketing authorization in the European Union.
Pancreatic cancer carries a poor prognosis, and it often goes undetected until advanced stages. A new BJS (British Journal of Surgery) study indicates that a certain cocktail of chemotherapy drugs may be a safe and effective treatment option for patients with a metastatic form of the disease.
Research calling for the use of a wearable computing system installed in a helmet to protect construction workers from carbon monoxide poisoning, a serious lethal threat in this industry, has garnered the Virginia Tech investigators a Best Paper Award from a prestigious scientific and engineering community.
Electromed, Inc. today announced financial results for the three-month period ended September 30, 2011. Net Revenues for the three months ended September 30, 2011 were approximately $5,379,000, a 29.1% increase compared to Net Revenues of approximately $4,165,000 for the same period last year.
› Verified 5 days ago
Kara M Lunzman, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 508 Moccasin Dr, Aberdeen, SD 57401 Phone: 605-225-4046 Fax: 605-225-9728 | |
Darren Dohman, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 310 8th Ave Nw Ste 503, Aberdeen, SD 57401 Phone: 605-225-2020 | |
Marshall Dorsett, Optometrist Medicare: Accepting Medicare Assignments Practice Location: 310 8th Ave Nw Ste 503, Aberdeen, SD 57401 Phone: 605-225-2020 | |
Sara Serfoss, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 310 8th Ave Nw Ste 503, Aberdeen, SD 57401 Phone: 605-225-2020 Fax: 605-725-2614 | |
James Olson, OD Optometrist Medicare: Medicare Enrolled Practice Location: 310 8th Ave Nw Ste 503, Aberdeen, SD 57401 Phone: 605-225-2020 | |
Robert W Dohman, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 3820 7th Ave Se, Aberdeen, SD 57401 Phone: 605-725-5110 Fax: 605-725-5111 |